|
Antidepressant Treatment of Melancholia in Late Life Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Antidepressant Treatment of Melancholia in Late Life conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Antidepressant Treatment of Melancholia in Late Life Clinical research trials and Antidepressant Treatment of Melancholia in Late Life medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Antidepressant Treatment of Melancholia in Late Life. Antidepressant Treatment of Melancholia in Late Life Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Antidepressant Treatment of Melancholia in Late Life clinical trial. Participants frequently obtain the most expert healthcare available for their Antidepressant Treatment of Melancholia in Late Life condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > Antidepressant Treatment of Melancholia in Late Life  Antidepressant Treatment of Melancholia in Late Life
Antidepressant Treatment of Melancholia in Late Life
For Condition: Depression,Melancholia
Status: Recruiting
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: The purpose of this study is to compare the safety and effectiveness of a select serotonin re-uptake inhibitor (SSRI, sertraline) and a tricyclic antidepressant (TCA, nortriptyline) in outpatients over the age of 60 who have major depression. SSRIs are effective in the treatment of major depression. However, there is also evidence that SSRIs may be significantly less effective than TCAs for patients with late-life major depression with melancholia. Since SSRIs seem to be easier to take than TCAs and are more widely prescribed, it is important to determine which of these types of antidepressants works best to treat these patients. Patients will be assigned randomly to receive either sertraline (a SSRI) or nortriptyline (a TCA) for 12 weeks. Patients will be monitored for symptoms, side effects, and quality of life. If a patient responds to treatment, he/she will participate in a 6-month continuation phase in which he/she will continue to receive the same medication. An individual may be eligible for this study if he/she: Has unipolar major depression (with some exceptions) and is over 60 years old.
Details: To compare the efficacy and safety of a select serotonin re-uptake inhibitor (SSRI, sertraline) and a tricyclic antidepressant (TCA, nortriptyline) in outpatients over the age of 60 who meet DSM-IV criteria for unipolar major depression, excluding patients who meet criteria for psychotic or atypical subtype. To test the hypothesis that medication condition interacts with diagnostic subtype (melancholic vs non-melancholic) in determining antidepressant response. To examine the roles of symptom severity and alternative diagnostic subtyping in contributing to this pattern. SSRIs are effective in the treatment of major depression. However, there is also evidence that SSRIs may be significantly less effective than TCAs for depressed patients with melancholia. This issue is of particular concern in late-life major depression. SSRIs have important safety advantages with respect to overdose and a benign cardiovascular profile. Furthermore, the SSRIs do not have significant anticholinergic effects, and appear to be better tolerated than the TCAs. Perhaps most important, the SSRIs currently are prescribed widely as the medication treatment of first choice for major depression in late life. Therefore, if it were determined that SSRIs are considerably less effective than TCAs in the treatment of melancholia in the elderly, there would be significant ramifications for clinical practice. Randomization to sertraline (a SSRI) or nortriptyline (a TCA) is stratified by the presence or absence of melancholia. Outcome measures for the 12-week acute phase include clinician and patient ratings of symptoms, side effects, and an evaluation of the health-related quality of life (HRQOL). At the end of the acute treatment phase, patients who meet criteria for clinical response participate in a 6-month continuation phase.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Parallel Assignment
Minimum Age/Maximum Age: 60 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: Patients must have: Unipolar major depression (per DSM-IV criteria) with or without melancholia. Exclusion Criteria: Patients with the following symptoms or conditions are excluded: Psychotic or atypical subtype of unipolar major depression.
Total Enrollment:
Location and Contact Information:
Overall Study Official:
StevenRoose, Principal Investigator,
1051 Riverside Drive *Recruiting*
New York City, New York, 10032
United States
Recruiting Steven Roose
Additional Information:
Study ID Numbers: MH55716;
Study Start Date: July 1997
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000378
Other Depression Studies:
1. Women's Use of Alternative Medicine: A Multiethnic Study
2. Brain Imaging in Depression
3. Preventing Depression in Patients with Macular Degeneration
4. Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer
5. Treatment Of Resistant Depression In Adolescents (TORDIA)
Related Studies:
Other Depression Clinical Trials
Other New York Clinical Trials
Other New York City Clinical Trials
Antidepressant Treatment of Melancholia in Late Life
|
|
|
|
|
|
|
|
